Due: June 4, 2026 The purpose of this notice of funding opportunity (NOFO) is to support the establishment or continuation of longitudinal infant cohorts to determine and compare how initial and repeated natural influenza infections Read More
Due: June 2, 2026 This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition Read More
Due: May 26, 2026 TechConnect’s client, an international snack and candy producer, seeks innovative food-safe lubricants for use on its confectionary production lines. Proposed solutions must allow for extended manufacturing time without product accumulation on Read More
Due: May 11, 2026 The objective of this RFI is to assess the current landscape of human-relevant neuromuscular junction (NMJ) micro-physiological systems (MPS) and their potential application for botulinum neurotoxin (BoNT) detection, potency measurement, and Read More
Due: April 15, 2026 The objective of this SSN / RFI is to better refine the requirements for host directed therapeutics for the prevention of progression to acute respiratory distress syndrome (ARDS) in support of Read More
Due: April 17, 2026 CPE CBRND is conducting essential market research for the Host-Directed Therapeutics (HD TX) program, a new initiative expected to launch in Fiscal Year 2027. This program is dedicated to identifying and Read More
Due: April 24, 2026 JPM CBRN Integrated Early Warning is developing AI/ML models to monitor physiological status, predict CBRN-related effects, and support Warfighter tactical decision making, readiness, and recovery. JPM CBRN Integrated Early Warning also Read More
Due: May 25, 2026 The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to provide Read More
Due: May 25, 2026 The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.